“My first visit, all staff were very polite and informative.”
Trouble Seeing at Night or in Dim Light
When to Seek Prompt Care
Night vision difficulty alone is rarely a same-day emergency, but certain symptoms alongside it deserve timely attention. Knowing what to watch for can help you decide how urgently to seek evaluation.
If difficulty seeing in the dark is accompanied by flashes of light, a sudden increase in floaters, or a shadow or curtain across part of your vision, seek care promptly. These symptoms can indicate a retinal tear or detachment, which is a true ocular emergency requiring same-day evaluation. A torn or detached retina can lead to permanent vision loss if not treated quickly.
Certain patients should be evaluated without delay if they develop night vision problems. A family history of RP or another inherited retinal disease makes night vision difficulty more significant and warrants a comprehensive workup. Patients who have had bariatric surgery or gastrointestinal conditions that impair nutrient absorption should be evaluated for vitamin A deficiency. People with diabetes who notice worsening night vision should be assessed for progression of diabetic retinopathy. Patients taking hydroxychloroquine or chloroquine who develop new visual symptoms should notify both their prescribing physician and their Retina Specialist.
Gradual difficulty with night driving that has developed over years in someone with known cataracts is typically related to the lens and can be addressed at a routine appointment. Mild, stable difficulty adapting to the dark that has already been evaluated and has not changed does not require urgent care. However, any progression in night vision difficulty or the appearance of new visual symptoms should prompt a call to your Retina Specialist to determine the next step.
How We Evaluate Night Vision Problems
Our team uses a structured, comprehensive approach to identify what is affecting your night vision. The combination of examination, functional testing, and advanced imaging gives us a clear picture of what is happening in the retina.
A dilated examination allows your Retina Specialist to view the retina in detail, with particular attention to the peripheral retina where rod photoreceptors are most concentrated. In RP, characteristic findings include bone-spicule-shaped pigment deposits in the mid-peripheral retina, narrowed retinal blood vessels, and a pale optic disc. The macula is examined for signs of AMD, macular edema, or other associated changes. The lens is also assessed, since cataracts develop more frequently in patients with inherited retinal diseases.
Visual field testing maps the extent of a patient's peripheral vision and helps detect and measure any constriction. Goldmann kinetic perimetry is especially useful for evaluating the pattern and severity of field loss in retinal dystrophies. Automated perimetry, such as Humphrey testing, measures sensitivity across the central visual field. Serial testing over time provides objective documentation of whether the condition is stable or progressing.
Electroretinography (ERG) measures the electrical responses of the retina to flashes of light. It is the most definitive test for evaluating rod and cone function. A full-field ERG records responses from the entire retina and can distinguish between conditions that primarily affect rods, cones, or both cell types.
In RP, the ERG shows reduced or absent rod responses, which is diagnostic even in early stages when the retina may still appear relatively normal. In CSNB, the ERG shows a different characteristic pattern that distinguishes it from progressive diseases. ERG results guide diagnosis, prognosis, and decisions about genetic counseling or clinical trial eligibility.
Optical coherence tomography (OCT) produces detailed cross-sectional images of the retinal layers and shows how much photoreceptor tissue remains intact. In RP, OCT reveals thinning of the outer nuclear layer and loss of the photoreceptor ellipsoid zone, starting in the outer retina and advancing inward over time. The width of the preserved ellipsoid zone on OCT correlates with remaining visual function.
Fundus autofluorescence imaging reveals the health of the retinal pigment epithelium and can show a ring of increased signal in RP that marks the boundary between functioning and degenerating retina. Widefield imaging captures peripheral retinal changes across a broad area. OCT angiography, fluorescein angiography, and B-scan ultrasound are also available when additional detail is needed.
When an inherited retinal disease is suspected, genetic testing can identify the specific gene mutation responsible. This is important for several reasons: it provides a definitive diagnosis, informs prognosis, guides counseling for family members, and determines whether a patient may be eligible for gene therapy or an ongoing clinical trial. Dozens of genes are associated with RP alone, each carrying its own rate of progression and pattern of vision loss. Our team may recommend referral to a genetic counselor to help patients and families understand the results and their implications.
Conditions We May Find
After a full evaluation, your Retina Specialist will review all findings and explain what is causing your night vision difficulty. Here are the most common conditions we identify and what they mean for your care.
RP is confirmed through the combination of clinical examination findings, ERG abnormalities, and often genetic testing. The prognosis depends on the specific genetic subtype, with some forms progressing slowly over many decades and others leading to more significant vision loss earlier in life. Our team will discuss what your particular form of RP is likely to mean for your vision over time and what options are available to protect and preserve it.
Vitamin A deficiency is diagnosed through a blood test and is one of the few fully reversible causes of night blindness (nyctalopia, meaning difficulty seeing in the dark). Once supplementation is started and levels are restored, rod function typically improves. Our team will coordinate with your primary care physician or gastroenterologist to address the underlying cause of the deficiency and prevent it from recurring.
In patients over 50, impaired dark adaptation may be an early sign of AMD, sometimes appearing before other visible changes. If AMD is found, OCT and fundus examination may reveal drusen (small deposits under the retina) and changes in retinal pigmentation. Our team will recommend a monitoring plan and may suggest nutritional supplements based on the AREDS2 formula. Home monitoring with an Amsler grid or a digital monitoring tool helps detect changes between office visits.
CSNB, choroideremia, Usher syndrome, and other inherited retinal diseases may be identified through the combination of clinical examination, ERG patterns, and genetic testing. Usher syndrome, which combines RP with hearing loss, is the most common inherited cause of combined deaf-blindness. Each of these conditions has a distinct natural history and genetic basis. Accurate diagnosis matters deeply because it shapes the counseling we provide to patients and their families.
Treatment Options
Treatment depends entirely on the underlying cause of night vision difficulty. Our team will explain which options apply to your situation and what level of benefit you might realistically expect from each.
Voretigene neparvovec (Luxturna) is an FDA-approved gene therapy for patients with vision loss caused by mutations in the RPE65 gene, which is associated with certain forms of RP and Leber congenital amaurosis. The treatment delivers a working copy of the RPE65 gene directly into retinal cells through a surgical injection beneath the retina. Patients who receive it may experience improved light sensitivity and better function in dim environments.
Eligibility requires confirmed mutations in both copies of the RPE65 gene and sufficient living retinal cells to benefit from treatment. Additional gene therapy programs targeting other genetic forms of retinal dystrophy are currently in clinical trials.
When vitamin A deficiency is confirmed, supervised supplementation can restore night vision. The appropriate dosage and duration depend on how severe the deficiency is and what is causing it. For patients with RP, some specialists have discussed vitamin A palmitate supplementation based on studies suggesting a possible modest slowing of decline, but this approach should only be pursued under the direct guidance of your Retina Specialist because excessive vitamin A intake carries real risks.
When cataracts are contributing to night vision difficulty, removing the clouded lens and replacing it with a clear artificial one can significantly improve how much light reaches the retina. For patients who have both cataracts and an underlying retinal condition such as RP, surgery may provide meaningful improvement in dim-light vision even though the retinal disease itself remains. Our team will help you understand what degree of improvement is realistic given your overall retinal health.
For patients whose night vision loss cannot be fully corrected with medical or surgical treatment, practical strategies and assistive tools can meaningfully improve daily safety and independence. Night vision devices that amplify ambient light can assist with navigation in dim environments. Orientation and mobility training teaches safer movement in low-light situations. Improving lighting at home and work reduces the functional impact of impaired rod function.
Our team can provide referrals to low-vision rehabilitation specialists who help patients make the most of their remaining vision.
For progressive conditions such as RP, regular monitoring with ERG, OCT, and visual field testing documents the rate of change and helps identify treatable complications such as cystoid macular edema, which is swelling in the central retina. Ongoing follow-up also ensures patients are aware of emerging therapies and clinical trials for which they may become eligible. Genetic counseling provides guidance on inheritance patterns and what the diagnosis may mean for other family members.
Frequently Asked Questions
Below are answers to common questions we receive from patients experiencing night vision difficulty. These are meant to add practical guidance beyond what is covered in the sections above.
That depends on the cause. If a vitamin A deficiency is to blame, supplementation can often restore meaningful function. If cataracts are involved, surgery can make a real difference. For patients with RPE65-related retinal disease, gene therapy with voretigene neparvovec may improve light sensitivity and low-light navigation. For progressive inherited conditions without a specific approved treatment, our focus shifts to protecting remaining function, slowing decline where possible, and providing adaptive strategies so patients can manage safely in low-light environments.
If your difficulty seeing in the dark has been getting gradually worse, has started to affect your ability to drive safely at night, or is accompanied by any change in your peripheral vision, it is worth being evaluated. You should seek care promptly, rather than waiting, if you also notice sudden new floaters, flashes of light, or a shadow covering part of your vision, as these can indicate a retinal emergency. A Retina Specialist can determine within a single visit whether what you are experiencing requires urgent action, ongoing monitoring, or treatment.
Not necessarily. Night blindness, or nyctalopia, is a symptom, not a diagnosis. RP is the most well-known cause, but night vision difficulty can also result from vitamin A deficiency, cataracts, certain medications, congenital stationary night blindness, or early AMD. A thorough retinal examination, including electroretinography and imaging, allows your Retina Specialist to distinguish between these possibilities. If RP is suspected, genetic testing can confirm the diagnosis and identify the exact mutation involved, which shapes both prognosis and eligibility for certain therapies.
Yes, this combination deserves evaluation. Diabetic retinopathy, which is retinal damage caused by chronically elevated blood sugar, can progress quietly and affect vision in multiple ways. Worsening night vision in a patient with diabetes may signal progression of retinal disease that needs to be documented and addressed. Our team will examine the retina in detail and assess whether diabetic changes are contributing, whether treatment is appropriate, and how closely you should be followed going forward.
Genetic testing identifies the specific gene mutation causing your condition, which matters for several practical reasons. It confirms your diagnosis with precision, helps predict how quickly your condition may progress, allows us to counsel family members who may be at risk, and determines whether you are eligible for approved gene therapies or ongoing clinical trials. Not every patient with an inherited retinal disease needs genetic testing right away, but your Retina Specialist will advise whether it is appropriate for your situation and may recommend connecting with a genetic counselor to help you understand the results.
This is an important safety question and one our team takes seriously. Whether you can safely drive at night depends on the degree of vision loss, the stability of your condition, and applicable state regulations. Patients with significant peripheral visual field loss or severe impairment of night vision may not meet the legal or safety threshold for nighttime driving, even if daytime vision seems adequate. Your Retina Specialist can provide an honest assessment of your functional vision and help you understand your options, including referral to orientation and mobility specialists who can help you maintain independence safely.
See Our Team at Atlantic Retina Center
Night vision difficulty deserves expert attention, not a wait-and-see approach. At Atlantic Retina Center, our fellowship-trained, board-certified team specializes exclusively in the retina, vitreous, and macula, bringing focused expertise to every evaluation. We offer comprehensive diagnostic testing, advanced imaging, and the full range of retinal treatments available today. We look forward to helping you understand what is affecting your vision and what we can do together to protect it.